Blood is always in high demand across Canada but one company is a step closer in helping solve this problem. AVIVO in partnership with Canadian Light Source (CLS) at the University of Saskatchewan has found a way to change to modify the chemical structure of a sugar antigen on the surface of blood cells, thereby converting a Type A blood cell to a Type O the universal donor and President and CEO John Coleman joins Gormley to discuss the latest on this.